Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_provenance.
- NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_assertion description "[In a consecutive case series, cross-sectional study of 275 women referred for therapy of hyperlipidemia, (75 [27%] on estrogen replacement therapy [ERT]), our specific aim was to determine whether ERT-mediated thrombophilia and heterozygosity for the thrombophilic 20210 G/A prothrombin gene mutation interacted as risk factors for atherothrombotic cardiovascular disease (ATCVD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_provenance.
- NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_assertion evidence source_evidence_literature NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_provenance.
- NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_assertion SIO_000772 11230792 NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_provenance.
- NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_assertion wasDerivedFrom befree-20140225 NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_provenance.
- NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_assertion wasGeneratedBy ECO_0000203 NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP601407.RAcgOWUZ6L9y9O-IqbHprm1y8g3Hm9sJ4anA3sJYLTQs8130_provenance.